A TNF receptor antagonistic scFv, which is not secreted in mammalian cells, is expressed as a soluble mono- and bivalent scFv derivative in insect cells.
Single chain antibodies (scFv) are usually produced in E. coli, but generation of certain scFv derivatives, such as complex fusion proteins or glycosylated forms of scFv is restricted to eukaryotic expression systems. We investigated the production of soluble mono- and bivalent single chain antibodies (scFv) in eukaryotic cells and describe a cassette vector system for mammalian and baculovirus expression which is compatible with an established vector system for bacterial expression and phage display selection of scFvs. The applied model scFv was derived from a murine antibody (H398) against human tumor necrosis factor receptor 1 (TNFR60), known to be a potent antagonist of TNF action in its monomeric form and a potential therapeutic agent for treatment of TNF-mediated diseases. Surprisingly, the monomeric scFv form of H398 (scFv H398) is expressed but not secreted in different mammalian cells. In contrast, in insect cells using recombinant baculovirus, a monovalent scFv H398 and a bivalent scFv fusion protein with an human IgG1 Fc region were expressed and secreted with correctly processed signal sequence. Concerning the influence of valency of the model Ab and its derivatives on antigen binding affinity and neutralisation of TNF activity, we found that the mono- and bivalent form of scFv H398 possesses the same characteristics as proteolytically produced Fab H398 and original mAb H398, respectively. Furthermore, fusion of the Ig Fc protein to scFv H398 increase the in vitro half-life at 37 degrees C. We conclude that the described cassette vectors readily allow the eukaryotic expression of mono- and bivalent scFv derivatives to analyse the influence of valency of scFv molecules on antigen binding and biological activity.
Brocks
B
B
Institute of Cell Biology and Immunology, University of Stuttgart, Germany.
Rode
H J
HJ
Klein
M
M
Gerlach
E
E
Dübel
S
S
Little
M
M
Pfizenmaier
K
K
Moosmayer
D
D
D000818:Animals; D016367:Baculoviridae / Q000235:genetics*; D019556:COS Cells / Q000502:physiology; D002461:Cell Line, Transformed; D003001:Cloning, Molecular; D006224:Cricetinae; D018014:Gene Transfer Techniques; D006801:Humans; D007128:Immunoglobulin Fragments / Q000096:biosynthesis* / Q000235:genetics / Q000494:pharmacology; D007135:Immunoglobulin Variable Region / Q000096:biosynthesis* / Q000235:genetics / Q000494:pharmacology; D007668:Kidney / Q000502:physiology; D051379:Mice; D018124:Receptors, Tumor Necrosis Factor / Q000037:antagonists & inhibitors*; D012995:Solubility; D018411:Spodoptera / Q000821:virology*
D007128:Immunoglobulin Fragments; D007135:Immunoglobulin Variable Region; D018124:Receptors, Tumor Necrosis Factor